Opinion

Video

Biomarker Testing in Advanced Ovarian Cancer

Author(s):

Thomas J. Herzog, MD,John Chan, MD

Panelists discuss how biomarker testing for advanced ovarian cancer, including when and which biomarkers to test (such as HRD), plays a crucial role in guiding treatment decisions and personalizing patient care.

Video content above is prompted by the following:

  1. How do you typically approach biomarker testing for advanced ovarian cancer?
  • When do you test, and what type of testing do you perform?
  • Which biomarkers do you generally access (eg, HRD, etc), and how do these results help guide your treatment approach?
Related Content